Evidence-based guideline for the management of osteoporosis in men
Journal article
Fuggle, Nicholas R., Beaudart, Charlotte, Bruyère, Olivier, Abrahamsen, Bo, Al-Daghri, Nasser, Burlet, Nansa, Chandran, Manju, Rosa, Mario M., Cortet, Bernard, Demonceau, Céline, Dere, Willard, Halbout, Philippe, Hiligsmann, Mickaël, Kanis, John A., Kaufman, Jean-Marc, Kurth, Andreas, Lamy, Olivier, Laslop, Andrea, Maggi, Stefania, ... Harvey, Nicholas C.. (2024). Evidence-based guideline for the management of osteoporosis in men. Nature Reviews Rheumatology. 20(4), pp. 241-251. https://doi.org/10.1038/s41584-024-01094-9
Authors | Fuggle, Nicholas R., Beaudart, Charlotte, Bruyère, Olivier, Abrahamsen, Bo, Al-Daghri, Nasser, Burlet, Nansa, Chandran, Manju, Rosa, Mario M., Cortet, Bernard, Demonceau, Céline, Dere, Willard, Halbout, Philippe, Hiligsmann, Mickaël, Kanis, John A., Kaufman, Jean-Marc, Kurth, Andreas, Lamy, Olivier, Laslop, Andrea, Maggi, Stefania, Matijevic, Radmila, McCloskey, Eugene, Mobasheri, Ali, Prieto Yerro, Maria C., Radermecker, Régis P., Sabico, Shaun, Al-Saleh, Yousef, Silverman, Stuart, Veronese, Nicola, Rizzoli, René, Cooper, Cyrus, Reginster, Jean Yves and Harvey, Nicholas C. |
---|---|
Abstract | Historically, osteoporosis has been viewed as a disease of women, with research, trials of interventions and guidelines predominantly focused as such. It is apparent, however, that this condition causes a substantial health burden in men also, and that its assessment and management must ultimately be addressed across both sexes. In this article, an international multidisciplinary working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases presents GRADE-assessed recommendations for the diagnosis, monitoring and treatment of osteoporosis in men. The recommendations are based on a comprehensive review of the latest research related to diagnostic and screening approaches for osteoporosis and its associated high fracture risk in men, covering disease burden, appropriate interpretation of bone densitometry (including the use of a female reference database for densitometric diagnosis in men) and absolute fracture risk, thresholds for treatment, and interventions that can be used therapeutically and their health economic evaluation. Future work should specifically address the efficacy of anti-osteoporosis medications, including denosumab and bone-forming therapies. |
Year | 2024 |
Journal | Nature Reviews Rheumatology |
Journal citation | 20 (4), pp. 241-251 |
Publisher | Nature Publishing Group |
ISSN | 1759-4790 |
Digital Object Identifier (DOI) | https://doi.org/10.1038/s41584-024-01094-9 |
PubMed ID | 38485753 |
Scopus EID | 2-s2.0-85187870842 |
Page range | 241-251 |
Funder | European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) |
Publisher's version | License All rights reserved File Access Level Controlled |
Output status | Published |
Publication dates | |
Online | 14 Mar 2024 |
Publication process dates | |
Accepted | 09 Feb 2024 |
Deposited | 04 Jun 2025 |
Additional information | © Springer Nature Limited 2024. |
https://acuresearchbank.acu.edu.au/item/91y8w/evidence-based-guideline-for-the-management-of-osteoporosis-in-men
Restricted files
Publisher's version
7
total views0
total downloads7
views this month0
downloads this month